Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.38 |
| ▸ | GABRP | O00591 | 1/20 | 0.38 |
| ▸ | GABRD | O14764 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14389448 | 1.00 | APLNR (0.43) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL14385404 | 1.00 | APLNR (0.43) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL3227696 | 0.90 | CYP2C19 (0.43) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL3489123 | 0.90 | CYP2C19 (0.43) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL21703887 | 0.90 | CYP2C19 (0.43) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL3057990 | 0.90 | CYP2C19 (0.43) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL3057992 | 0.90 | CYP2C19 (0.43) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL19506522 | 0.84 | GABRR1 (0.46) | APLNRCYP2C19GABRR1CYP1A2ALOX15 | |
| SCHEMBL19506520 | 0.82 | APLNR (0.41) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 | |
| SCHEMBL6943949 | 0.80 | APLNR (0.39) | APLNRCYP2C19GABRR1CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109982724-A | Deodorant agent | 理研香料控股株式会社 | 2019-07-05 | — | — | CN | claimed |
| CN-1298279-A | Utilization of natural and/or synthetic quinic acid and/or precursors thereof as insect repellents | BIOCONNECTING TECH AG (CH) | 2001-06-06 | — | — | CN | claimed |
| CN-107353201-B | High-content natural shikimic acid extract and preparation method thereof | 云南希康生物科技有限公司 | 2021-02-02 | — | — | CN | disclosed |
| CN-107034051-B | One kind is containing amygdalate hair soap and preparation method thereof | 北京联合大学 | 2019-11-15 | — | — | CN | disclosed |
| CN-110437070-A | A kind of chlorogenic acid for preparing the method for high-purity chlorogenic acid as raw material comprehensive utilization using stevia rebaudian leaf and its being prepared | ZHUCHENG HAOTIAN PHARM CO LTD | 2019-11-12 | — | — | CN | disclosed |
| CN-108346493-B | A method of by changing plasma resonance strength reduction nano-silver thread transparent conductive film yellowing | 合肥微晶材料科技有限公司 | 2019-08-02 | — | — | CN | disclosed |
| CN-108346493-A | A method of by changing plasma resonance strength reduction nano-silver thread transparent conductive film yellowing | 合肥微晶材料科技有限公司 | 2018-07-31 | — | — | CN | disclosed |
| CN-108084044-A | A kind of climbing groundsel derivative and its application in drug | 湖南天济草堂制药股份有限公司 | 2018-05-29 | — | — | CN | disclosed |
| US-RE46698-E1 | Use of cyclohexanol derivatives as antimicrobial active compounds | MERCK PATENT GMBH (DE) | 2018-02-06 | — | — | US | disclosed |
| US-RE46698-E1 | Use of cyclohexanol derivatives as antimicrobial active compounds | MERCK PATENT GMBH (DE) | 2018-02-06 | — | — | US | disclosed |
| CN-106316830-A | Method for separation and purification of shikimic acid from ginkgo biloba leaves | 西南民族大学 | 2017-01-11 | — | — | CN | disclosed |
| WO-2009026176-A2 | ANTIINFECTIVE FLAVONONOL COMPOUNDS AND METHODS OF USE THEREOF | HERBALSCIENCE GROUP LLC (US) | 2009-02-26 | — | — | WO | disclosed |
| CN-1978422-A | Method for separating and purifying shikimic acid | SHANGHAI MEDICINE INST CHINESE (CN) | 2007-06-13 | — | — | CN | disclosed |
| EP-1762219-A1 | PHOTOPROTECTIVE AND/OR PHOTOIMMUNOPROTECTIVE COMPOSITIONS FOR THE SKIN AND USES THEREOF | Industrial Farmaceutica Cantabria, S.A. (ES) | 2007-03-14 | — | — | EP | disclosed |
| US-20070025933-A1 | Photoprotector and/or photoimmunoprotector compositions of the skin and their uses | INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. (ES) | 2007-02-01 | — | — | US | disclosed |
| CN-1298279-A | Utilization of natural and/or synthetic quinic acid and/or precursors thereof as insect repellents | BIOCONNECTING TECH AG (CH) | 2001-06-06 | — | — | CN | disclosed |
| EP-1065926-A1 | UTILIZATION OF NATURAL AND/OR SYNTHETIC QUINIC ACID AND/OR PRECURSORS THEREOF AS INSECT REPELLENTS | Biolink Technologies AG (CH) | 2001-01-10 | — | — | EP | disclosed |
| WO-1999048363-A1 | UTILIZATION OF NATURAL AND/OR SYNTHETIC QUINIC ACID AND/OR PRECURSORS THEREOF AS INSECT REPELLENTS | BIOLINK TECHNOLOGIES AG (CH) | 1999-09-30 | — | — | WO | disclosed |
| US-5240835-A | Reacting unsaturated ester with a polyol in presence of biocatalyst derived from Corynebacterium oxydans | GENENCOR INTERNATIONAL, INC. (US) | 1993-08-31 | — | — | US | disclosed |
| CN-85101563-A | The quinate preparation method of antimalarial compound Mefloquine | — | 1987-01-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070025933-A1 | Photoprotector and/or photoimmunoprotector compositions of the skin and their uses | ME1, ME2, SI | APLNR 3048/4885CYP2C19 2205/4885GABRR1 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.